Medipharm Labs Corp T.LABS

LABS research partner, McMaster to host 'infectious disease'

[subaru1i]

conference, that would include viruses like avian bird flu, and at DeGroote School of Medicine where research work on the anti viral, anti bacterial, antibiotic properties of cannabinoid pharmaceuticals was conducted.   Mr. Pidduck, you do not have yet true 'global capacity' relative to emerging demand within the realm of viruses.   Time is running out and running out very quickly.   For an intelligent species, I have to admit, humans make things so complicated and cumbersome.   A price paid for coveting the light that nurtures those cannabis plants but so too that light contains the Truth π and those amongst us that want to have 'their piece of cake and eat it too', just like monkeys,  that hide the Truth π of Life π within the nuclear fusion atmosphere of the Sun π.   Pentagon/NSA...enjoy your cake now and make sure you eat every bite. 

“Having more people in Canada who are trained in these areas will allow us to respond quickly to emerging infectious disease outbreaks, and to do so in a data-driven way,” says McArthur, a member of the Michael G. DeGroote Institute for Infectious Disease Research.  

Technical Update: Summary Analysis of Genetic Sequences of Highly Pathogenic Avian Influenza A(H5N1) Viruses in Texas

April 2, 2024 – CDC has sequenced the influenza virus genome identified in a specimen collected from the patient in Texas who was confirmed to be infected with highly pathogenic avian influenza A(H5N1) [“HPAI A(H5N1)”] virus